Clinical Trial

The Effect of Laughter Yoga on Symptom Severity, Depression-anxiety-stress, Sleep Quality and Quality of Life in Patients with Irritable Bowel Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 3, 2025 (before its estimated January 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study will be conducted to evaluate the effect of laughter yoga on symptom severity, depression, anxiety, stress, sleep and quality of life in patients with Irritable Bowel Syndrome (IBS). The following hypotheses will be tested in this study: H1: Laughter yoga reduces symptom severity in patients with IBS. H2: Laughter yoga reduces depression, anxiety and stress in patients with IBS. H3: Laughter yoga improves sleep quality in patients with IBS. H4: Laughter yoga improves quality of life in patients with IBS.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-22; most recent amendment 2025-01-02.
Status change: Not Yet Recruiting → Recruiting 2025-01-02
Trial Details
NCT Number NCT06705153
Lead Sponsor Ataturk University
Conditions Irritable Bowel Syndrome
Enrollment 56 participants
Start Date 2024-12-04
Primary Completion 2025-01-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-01-03